Clinical Trial Update: Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation and safety study of human spinal cord–derived neural stem cell transplantation for amyotrophic lateral sclerosis is underway. The curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NSI-566 Neural Stem Cells (neural stem cells)

Snippet

Sponsor: Neuralstem Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN